Suppr超能文献

在过表达人肽转运体的Caco-2/hPEPT1细胞中氨基酸酯前药的细胞摄取机制

Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.

作者信息

Han H K, Oh D M, Amidon G L

机构信息

College of Pharmacy, The University of Michigan, Ann Arbor 48109-1065, USA.

出版信息

Pharm Res. 1998 Sep;15(9):1382-6. doi: 10.1023/a:1011945420235.

Abstract

PURPOSE

This study characterized the cellular uptake mechanism and hydrolysis of the amino acid ester prodrugs of nucleoside antiviral drugs in the transiently transfected Caco-2 cells overexpressing a human intestinal peptide transporter, hPEPT1 (Caco-2/hPEPT1 cells).

METHODS

Amino acid ester prodrugs of acyclovir and AZT were synthesized and their apical membrane permeability and hydrolysis were evaluated in Caco-2/hPEPT1 cells. The cellular uptake mechanism of prodrugs was investigated through the competitive inhibition study in Caco-2/hPEPT1 cells.

RESULTS

L-Valyl ester of acyclovir (L-Val-ACV) was approximately ten fold more permeable across the apical membrane than acyclovir and four times more permeable than D-valyl ester of acyclovir (D-Val-ACV). Correspondingly, L-valyl ester of AZT (L- Val-AZT) exhibited three fold higher cellular uptake than AZT. Therefore, amino acid ester prodrugs significantly increased the cellular uptake of the parent drugs and exhibited the D,L-stereoselectivity. Furthermore, prodrugs were rapidly hydrolyzed to the parent drugs by the intracellular hydrolysis, following the apical membrane transport. In the inhibition studies, cephalexin and small dipeptides strongly inhibited the cellular uptake of L-Val-ACV while L-valine had no effect, indicating that the peptide transporter is primarily responsible for the apical membrane transport of L-Val-ACV. In addition, the cellular uptake of L-Val-ACV was five times higher in Caco-2/hPEPT1 cells than the uptake in the untransfected Caco-2 cells, implying the cellular uptake of L-Val-ACV was related to the enhancement of the peptide transport activity in Caco-2/hPEPT1 cells.

CONCLUSIONS

Caco-2/hPEPT1 system is an efficient in vitro model for the uptake study of peptidyl derivatives. Amino acid ester prodrugs significantly improved the cellular uptake of the parent drugs via peptide transport mechanism and were rapidly converted to the active parent drugs by the intracellular hydrolysis.

摘要

目的

本研究对过表达人肠道肽转运体hPEPT1的瞬时转染Caco - 2细胞(Caco - 2/hPEPT1细胞)中核苷类抗病毒药物氨基酸酯前药的细胞摄取机制及水解情况进行了表征。

方法

合成了阿昔洛韦和齐多夫定的氨基酸酯前药,并在Caco - 2/hPEPT1细胞中评估了它们的顶膜通透性和水解情况。通过在Caco - 2/hPEPT1细胞中的竞争性抑制研究,对前药的细胞摄取机制进行了研究。

结果

阿昔洛韦的L - 缬氨酸酯(L - Val - ACV)跨顶膜的通透性比阿昔洛韦高约10倍,比阿昔洛韦的D - 缬氨酸酯(D - Val - ACV)高4倍。相应地,齐多夫定的L - 缬氨酸酯(L - Val - AZT)的细胞摄取量比齐多夫定高3倍。因此,氨基酸酯前药显著增加了母体药物的细胞摄取,并表现出D,L - 立体选择性。此外,前药在通过顶膜转运后,通过细胞内水解迅速水解为母体药物。在抑制研究中,头孢氨苄和小肽强烈抑制L - Val - ACV的细胞摄取,而L - 缬氨酸则无作用,表明肽转运体主要负责L - Val - ACV的顶膜转运。此外,L - Val - ACV在Caco - 2/hPEPT1细胞中的细胞摄取量比未转染的Caco - 2细胞高5倍,这意味着L - Val - ACV的细胞摄取与Caco - 2/hPEPT1细胞中肽转运活性的增强有关。

结论

Caco - 2/hPEPT1系统是用于肽基衍生物摄取研究的高效体外模型。氨基酸酯前药通过肽转运机制显著提高了母体药物的细胞摄取,并通过细胞内水解迅速转化为活性母体药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验